Metropolitan Life Insurance Company (MetLife)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,461
| Closed | -$361K | – | 2753 |
|
|
2021
Q4 | $361K | Buy |
2,461
+137
| +6% | +$20.1K | ﹤0.01% | 1625 |
|
|
2021
Q3 | $411K | Sell |
2,324
-77
| -3% | -$13.6K | 0.01% | 1581 |
|
|
2021
Q2 | $388K | Sell |
2,401
-8,946
| -79% | -$1.45M | 0.01% | 1689 |
|
|
2021
Q1 | $1.94M | Sell |
11,347
-469
| -4% | -$80.3K | 0.03% | 528 |
|
|
2020
Q4 | $2.6M | Buy |
11,816
+1,089
| +10% | +$239K | 0.04% | 377 |
|
|
2020
Q3 | $1.78M | Sell |
10,727
-443
| -4% | -$73.6K | 0.03% | 459 |
|
|
2020
Q2 | $1.28M | Buy |
11,170
+2,222
| +25% | +$254K | 0.02% | 600 |
|
|
2020
Q1 | $688K | Buy |
8,948
+421
| +5% | +$32.4K | 0.01% | 872 |
|
|
2019
Q4 | $1.1M | Sell |
8,527
-179
| -2% | -$23.1K | 0.02% | 839 |
|
|
2019
Q3 | $678K | Buy |
8,706
+1,517
| +21% | +$118K | 0.01% | 1100 |
|
|
2019
Q2 | $740K | Buy |
7,189
+319
| +5% | +$32.9K | 0.01% | 1071 |
|
|
2019
Q1 | $504K | Buy |
6,870
+419
| +6% | +$30.7K | 0.01% | 1295 |
|
|
2018
Q4 | $274K | Buy |
6,451
+382
| +6% | +$16.2K | 0.01% | 1607 |
|
|
2018
Q3 | $286K | Hold |
6,069
| – | – | ﹤0.01% | 1744 |
|
|
2018
Q2 | $299K | Buy |
+6,069
| New | +$299K | ﹤0.01% | 1663 |
|
|
2016
Q2 | – | Sell |
-10,368
| Closed | -$222K | – | 2697 |
|
|
2016
Q1 | $222K | Hold |
10,368
| – | – | ﹤0.01% | 2110 |
|
|
2015
Q4 | $328K | Buy |
10,368
+2,664
| +35% | +$84.3K | ﹤0.01% | 1904 |
|
|
2015
Q3 | $265K | Hold |
7,704
| – | – | ﹤0.01% | 2080 |
|
|
2015
Q2 | $242K | Buy |
7,704
+366
| +5% | +$11.5K | ﹤0.01% | 2268 |
|
|
2015
Q1 | $215K | Buy |
+7,338
| New | +$215K | ﹤0.01% | 2029 |
|